TrialJournal of psychopharmacology (Oxford, England)2026
The effects of the PDE4 inhibitor roflumilast on cognitive performance after a cerebrovascular accident: a double-blind randomized placebo-controlled trial with an open label extension (ROSTMEMA).
Jill Kerckhoffs et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.